action of glp 1 agonist GLP-1 Agonists Trends in the Development of

Mol Pharmacol (2005) 68(3):84754

The first copper peptide serum spray to combine 2400mg of AHK-Cu and 2400mg of GHK-Cu in a 1:1 ratio to support skin, scalp, and hair

A double-blind, randomized phase 2 study comparing various doses (1, 5, 10, 15 mg) of once weekly tirzepatide, dulaglutide (1.5 mg) and placebo, in patients with T2DM, showed tirzepatide was superior on weight loss and glucose-lowering compared to both dulaglutide and placebo [52]

A Research Use Only statement does not necessarily settle classification where the wider presentation promotes personal use, recovery, injury treatment, inflammation control or another medicinal purpose

We treat a range of common concerns from pigmentation and acne to ageing and sensitivity